BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37620175)

  • 1. Intralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis.
    Pamonag MZ; Seery AM; Omari AIA; Alnouri G; Sataloff RT
    J Voice; 2023 Aug; ():. PubMed ID: 37620175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
    Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
    Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
    Broekema FI; Dikkers FG
    Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ; Akst LM; Koltai PJ
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
    Lee AS; Rosen CA
    J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
    Milczuk HA
    Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
    Sheahan P; Sexton S; Russell JD
    J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.
    Dikkers FG
    Eur Arch Otorhinolaryngol; 2006 May; 263(5):440-3. PubMed ID: 16328406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
    Chhetri DK; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1081-5. PubMed ID: 14568791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
    Hoesli RC; Thatcher AL; Hogikyan ND; Kupfer RA
    JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):231-236. PubMed ID: 31895450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
    Pransky SM; Brewster DF; Magit AE; Kearns DB
    Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
    Mandell DL; Arjmand EM; Kay DJ; Casselbrant ML; Rosen CA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1319-23. PubMed ID: 15545589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.